SOBI.ST
Price:
$325.2
Market Cap:
$111.69B
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, ...[Read more]
Industry
Drug Manufacturers - Specialty & Generic
IPO Date
2006-09-15
Stock Exchange
STO
Ticker
SOBI.ST
According to Swedish Orphan Biovitrum AB (publ)’s latest financial reports and current stock price. The company's current ROE is 9.82%. This represents a change of 299.79% compared to the average of 2.46% of the last 4 quarters.
The mean historical ROE of Swedish Orphan Biovitrum AB (publ) over the last ten years is 11.87%. The current 9.82% ROE has changed -17.31% with respect to the historical average. Over the past ten years (40 quarters), SOBI.ST's ROE was at its highest in in the June 2018 quarter at 8.73%. The ROE was at its lowest in in the December 2014 quarter at -0.39%.
Average
11.87%
Median
13.33%
Minimum
-5.92%
Maximum
26.75%
Discovering the peaks and valleys of Swedish Orphan Biovitrum AB (publ) ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 936.06%
Maximum Annual ROE = 26.75%
Minimum Annual Increase = -124.63%
Minimum Annual ROE = -5.92%
Year | ROE | Change |
---|---|---|
2023 | 7.11% | -28.48% |
2022 | 9.95% | -13.86% |
2021 | 11.55% | -28.11% |
2020 | 16.06% | -17.71% |
2019 | 19.52% | -27.03% |
2018 | 26.75% | 56.02% |
2017 | 17.14% | 13.44% |
2016 | 15.11% | 936.06% |
2015 | 1.46% | -124.63% |
2014 | -5.92% | 203.82% |
The current ROE of Swedish Orphan Biovitrum AB (publ) (SOBI.ST) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
9.53%
5-year avg
12.84%
10-year avg
11.87%
Swedish Orphan Biovitrum AB (publ)’s ROE is less than Getinge AB (publ) (5.44%), less than Elekta AB (publ) (10.78%), less than AB SKF (publ) (10.11%), less than Saab AB (publ) (11.70%), less than Essity AB (publ) (26.22%),
Company | ROE | Market cap |
---|---|---|
5.44% | $50.65B | |
10.78% | $23.15B | |
10.11% | $92.56B | |
11.70% | $118.00B | |
26.22% | $204.29B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Swedish Orphan Biovitrum AB (publ) using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Swedish Orphan Biovitrum AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Swedish Orphan Biovitrum AB (publ)'s ROE?
How is the ROE calculated for Swedish Orphan Biovitrum AB (publ) (SOBI.ST)?
What is the highest ROE for Swedish Orphan Biovitrum AB (publ) (SOBI.ST)?
What is the 3-year average ROE for Swedish Orphan Biovitrum AB (publ) (SOBI.ST)?
What is the 5-year average ROE for Swedish Orphan Biovitrum AB (publ) (SOBI.ST)?
How does the current ROE for Swedish Orphan Biovitrum AB (publ) (SOBI.ST) compare to its historical average?